Results 281 to 290 of about 185,950 (370)
Refractory anaemia in a patient with end‐stage heart failure secondary to aortic stenosis
ESC Heart Failure, Volume 12, Issue 5, Page 3766-3770, October 2025.
Jiayu Liang, Suxin Luo, Bi Huang
wiley +1 more source
ABSTRACT Background Liver stiffness measurement (LSM) and spleen stiffness measurement (SSM) represent non‐invasive surrogates of portal hypertension (PH) that both correlate with hepatic venous pressure gradient (HVPG). SSM may overcome limitations of HVPG and LSM in detecting presinusoidal PH components.
Christian Sebesta +17 more
wiley +1 more source
The future of siRNA-mediated approaches to treat von Willebrand disease. [PDF]
Linthorst NA +2 more
europepmc +1 more source
ABSTRACT Background and Aims Smoking induces a proinflammatory state, yet its role in advanced chronic liver disease (ACLD) remains understudied. This study evaluated its impact on disease‐driving mechanisms and clinical outcomes in ACLD patients. Methods ACLD patients undergoing hepatic venous pressure gradient measurements from 2017 to 2021 were ...
Nina Dominik +14 more
wiley +1 more source
Clinical utility of panel-based genetic sequencing for von Willebrand disease. [PDF]
Ramanan R +12 more
europepmc +1 more source
ABSTRACT Background and Aims Neutrophil extracellular traps (NETs) are part of the body's innate immune response. In animal models, NETs aggravated liver injury and promoted disease progression/portal hypertension by the formation of (micro)thrombi leading to parenchymal extinction.
Lorenz Balcar +17 more
wiley +1 more source
2025 ASH ISTH NBDF WFH monitoring report on the 2021 clinical guidelines on the diagnosis and management of von Willebrand disease. [PDF]
James PD, Flood VH, Connell NT.
europepmc +1 more source

